Skip to main content
Log in

Alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV)—awareness prevents extended or futile ECMO use

  • Original Article
  • Published:
Indian Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Background

Alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV) is a rare, fatal, congenital lung disorder involving abnormal development of the capillary vascular system around the alveoli of the lungs, which clinically presents as persistent pulmonary hypertension of the newborn (PPHN) refractory to treatment. It has been linked to the gene FOXF1 on chromosome 16q24.1–q24.2. Histopathological examination by lung biopsy is the gold standard for diagnosis.

Materials and methods

We present four cases of ACD/MPV who were referred for ECMO support with a diagnosis of PPHN with no apparent congenital anomalies.

Results

All the newborns had an overwhelming course, with PPHN and hypoxemia refractory to treatment. The diagnosis of ACD/MPV was established by ante-mortem lung biopsy in all cases. Intensive care treatment was withdrawn post diagnosis, with none of the four surviving.

Conclusions

Early lung biopsy for a histological diagnosis allows expensive and ineffective treatment to be avoided. Lung biopsy can be performed with low risk and high-diagnostic yield for alveolar capillary dysplasia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Abu-Shaweesh JM. Respiratory disorders in preterm and term infants. In: Martin RJ, Fanaroff AA, Walsh MC, editors. Fannaroff and Martin’s neonatal-perinatal medicine, diseases of the fetus and infant. 9th ed. St Louis: Elsevier Mosby; 2011. p. 1141–70.

    Google Scholar 

  2. Bishop NB, Stankiewicz P, Steinhorn RH. Alveolar capillary dysplasia. Am J Res Crit Care Med. 2011;184:172–9.

    Article  Google Scholar 

  3. Ahmed S, Ackerman V, Faught P, Langston C. Profound hypoxemia and pulmonary hypertension in a 7-month-old infant: late presentation of alveolar capillary dysplasia. Pediatr Crit Care Med. 2008;9:e43–6.

    Article  PubMed  Google Scholar 

  4. Shankar V, Haque A, Johnson J, Pietsch J. Late presentation of alveolar capillary dysplasia in an infant. Pediatr Crit Care Med. 2006;7:177–9.

    Article  PubMed  Google Scholar 

  5. Sihoe A, Lee AT, To KF, Thumg KH, Lee TW, Yim AP. Alveolar capillary dysplasia with congenital misalignment of pulmonary vessels. Asian Cardiovasc Thorac Ann. 2005;13:82–4.

    Article  PubMed  Google Scholar 

  6. Chelliah BP, Brown D, Cohen M, Talleyrand AJ, Shen-Schwarz S. Alveolar capillary dysplasia—a cause of persistent pulmonary hypertension unresponsive to a second course of extracorporeal membrane oxygenation. Pediatrics. 1995;96:1159–61.

    CAS  PubMed  Google Scholar 

  7. Steinhorn RH, Cox PN, Fineman JR, et al. Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr. 1997;130:417–22.

    Article  CAS  PubMed  Google Scholar 

  8. Lazar DA, Olutoye OO, Cass DL, et al. Outcomes of neonates requiring extracorporeal membrane oxygenation for irreversible pulmonary dysplasia: the extracorporeal life support registry experience. Pediatr Crit Care Med. 2012;13:188–90.

    Article  PubMed  Google Scholar 

  9. Extracorporeal Life Support Organization. ECLS Registry Report, International Summary. Ann Arbor, MI: Extracorporeal Life Support Organization; 2013. pp. 1–26.

  10. Chang KT, Rajadurai VS, Walford NQ, Hwang WS. Alveolar capillary dysplasia: absence of CD117 immunoreactivity of putative hemangioblast precursor cells. Fetal Pediatr Pathol. 2008;27:27–140.

    Article  Google Scholar 

  11. Tibballs J, Chow CW. Incidence of alveolar capillary dysplasia in severe idiopathic persistent pulmonary hypertension of the newborn. J Paediatr Child Health. 2002;38:397–400.

    Article  CAS  PubMed  Google Scholar 

  12. Stankiewicz P, Sen P, Bhatt SS, et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet. 2009;84:780–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Sirkin W, O’Hare BP, Cox PN, Perrin D, Cutz E, Silver MM. Alveolar capillary dysplasia: lung biopsy diagnosis, nitric oxide responsiveness, and bronchial generation count. Pediatr Pathol Lab Med. 1997;17:125–32.

    Article  CAS  PubMed  Google Scholar 

  14. Hagood JS. Children’s Interstitial Lung Disease (ChILD): eMedicine Pediatrics: General Medicine. 2009. Available from: http://emedicine.medscape.com/article/1003631-overview. Accessed 15 Aug 2012.

  15. Alameh J, Bachiri A, Devisme L, et al. Alveolar capillary dysplasia: a cause of persistent pulmonary hypertension of the newborn. Eur J Pediatr. 2002;161:262–6.

    Article  CAS  PubMed  Google Scholar 

  16. Children’s hospital, St. Luis: new medical approach helps baby with rare disease [internet] 2012 [updated July 18, 2012 cited Feb 3, 2014] Available from: http://www.stlouischildrens.org/articles/features/2012/new-medical-approach-helps-baby-with-rare-disease

Download references

Acknowledgments

The authors would like to thank Dr. O’neill (histopathologist).

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ullas Angadi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Angadi, U., Meedimale, V. & Robinson, S. Alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV)—awareness prevents extended or futile ECMO use. Indian J Thorac Cardiovasc Surg 30, 147–151 (2014). https://doi.org/10.1007/s12055-014-0291-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12055-014-0291-z

Keywords

Navigation